Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis

BACKGROUND: The treatment of myasthenia gravis (MG) has advanced from steroids and traditional immunosuppressants to targeted immunotherapy. Targeted immunotherapy has been successfully employed in clinical practice in recent years. This study aimed to explore the emerging trend of targeted immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yue, Ruan, Zhe, Wang, Rui, Hao, Sijia, Tang, Yonglan, Huang, Xiaoxi, Gao, Ting, Li, Zhuyi, Chang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557176/
https://www.ncbi.nlm.nih.gov/pubmed/36248874
http://dx.doi.org/10.3389/fimmu.2022.998217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557176/
https://www.ncbi.nlm.nih.gov/pubmed/36248874
http://dx.doi.org/10.3389/fimmu.2022.998217

Ejemplares similares